American Council of Cannabis Medicine

What American Council of Cannabis Medicine does

American Council of Cannabis Medicine (ACCM) is a 501(c)(4) nonprofit trade association founded in 2016 and headquartered in Washington D.C. (601 Pennsylvania Ave. NW, South Building, Suite 900). It operates as the coordinating body for the U.S. medical cannabis sector, with a stated focus on patient access, provider education, and federal policy advocacy. ACCM claims to represent an industry supporting more than one million U.S. jobs and positions itself as the "Voice of Medical Cannabis."

ACCM's core products and programs include Elevated States (state-level advocacy scaffold, now operating in all 50 states), Yes We Cann! (patient-facing communications), Next Frontier (insurance and healthcare integration platform launched June 2022), The Source (consumer and stakeholder portal, with an Affinity Program launched August 2023 and a Portal launched January 2026), the Midmarket Coalition, the ACCM Distinction Program, and the Faces of Medical Cannabis Campaign (June 2026). Its media operation includes 25+ publications and the Medical Cannabis News Network (MCNN), re-launched in October 2023. Engagement is structured through 15 standing committees, an 8,000+ member network, and a Stakeholder Alliance of 200+ organizations bound by an April 2021 MOU. Recent partnerships include Direct Primary Care Society (2024), Miller United (2023), Performance Health (2023), Wellness Live! (2023), a Chiropractic Association (2023), and the National Health Care Sharing Association (2022), plus the Patient First Coalition alignment (April 2025) in support of Schedule III rescheduling.

Revenue mechanics comprise membership dues, sponsorships, advertising, affinity/group purchasing, events, and trade missions. No financials, dues schedules, or staffing data are disclosed. The organization is governed as a 501(c)(4), which permits direct lobbying but precludes public charity tax filings; this constrains outside visibility into revenue scale and operating margin.

Name

American Council of Cannabis Medicine

Legal name

American Council of Cannabis Medicine

Website

https://accmforum.org

Company type

Private

Founded year

2016

Operating status

Operating

Short description

American Council of Cannabis Medicine is a 501(c)(4) nonprofit trade association founded in 2016 and headquartered in Washington D.C., coordinating U.S. medical cannabis advocacy, member services, and federal policy engagement across 8,000+ members, 15 committees, and 200+ alliance organizations.

Ownership category

akta.pro rank

Product category

Medical Cannabis Advocacy Services

NAICS

Business Associations (813910), Professional Organizations (81392), Professional Organizations (813920)

SIC

Services-Membership Organizations (8600)

akta.pro industry

PRIMARYTHAHACAA

Association & Society Conference Management (Nonprofit, Professional Bodies)

Travel & Hospitality/MICE (Meetings, Incentives, Conferences & Exhibitions)/Professional Conference Organizers (PCOs) & Meeting Planners

Keywords

• Medical cannabis advocacy
• Trade association services
• Policy advocacy organization
• Healthcare legislation support
• Nonprofit membership services

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Membership Dues: Annual membership fees from medical cannabis producers, processors, dispensaries, pharmacies, physicians, researchers, and allied industry companies. Membership categories include Primary Membership (Producer/Processor, Dispensary/Pharmacy, Pharmaceutical Companies, Researchers, Medical Practitioners) and Allied Industry Membership.
2. Sponsorships: Programming support and sponsorship opportunities including general sponsorships, legislative program support, event sponsorships, and special package supports targeting marketing needs.
3. Advertising: Advertising opportunities in ACCM publications and media channels. Media kit available with rate card and ad specs. ACCM Development Group handles advertising sales at 202-349-9650 ext. 825.
4. Affinity/Group Purchasing (The Source): The ACCM Source program provides affinity and group purchasing benefits to members, creating revenue through partnerships with vetted organizations. Program providers must create direct revenue for the association.
5. Events and Conferences: Registration fees for Policy Action Institute (Non-Member: $200, Member: $100, Discounted: $75, Student: $50), Midmarket Coalition sessions, and other industry events.
6. Trade Missions: AIM Trade Missions connecting international and domestic groups with the American medical cannabis industry through facilitated meetings, tours, and networking events.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels9 records

Core offering

ACCM is a 501(c)(4) nonprofit trade association that operates as the national advocacy and policy organization for the U.S. medical cannabis industry. It provides government affairs representation, legislative advocacy, industry publications (including the Medical Cannabis News Network), member benefits programs, peer networking, and standards-setting services. The organization recruits members from medical cannabis producers, processors, dispensaries, pharmacies, physicians, researchers, pharmaceutical companies, and allied industry firms.

Product overview

The American Council of Cannabis Medicine (ACCM) operates as a nonprofit trade association and advocacy organization rather than a software product company. Its portfolio consists of advocacy programs, media/publication products, member services, and industry support tools. The core offerings include: the Medical Cannabis News Network (MCNN) and related publications (Medical Cannabis Monthly, Inside ACCM Newsletter, Washington Insight) for industry news and information; Elevated States and Yes We Cann! for state-level engagement and advocacy; The Source affinity program for member business savings; Midmarket Coalition for CEO peer networking; ACCM Leaders Bureau connecting media with industry experts; Next Frontier for third-party payer integration; and the ACCM Distinction Program for industry standards. ACCM also runs Policy Action Institute events, AIM Trade Missions, Stay On Target patient education, and Citizen Advocates Action Hub. The organization is structured around 15 standing committees and serves as the national voice for the medical cannabis industry.

Differentiator

Problem solved

Functional benefit

Brands

• Elevated States: ACCM's comprehensive state engagement, outreach, advocacy and education program that connects patients with dispensaries and physicians
• Yes We Cann!
• Medical Cannabis News Network (MCNN)
• Next Frontier
• The Source
• Midmarket Coalition
• We Are MedCann
• ACCM Leaders Bureau
• AIM Trade Missions
• Medical Cannabis Awareness Month
• Patient First Coalition
• ACCM Distinction Program

Products and services

• Medical Cannabis News Network (MCNN) Comprehensive online news network publishing continuously throughout the year with medical-cannabis industry news, breaking news alerts, feature stories, expert columns, legislative updates, and industry highlights. Available to members and the broader industry.
• Elevated States Comprehensive state engagement, outreach, advocacy, and education program connecting patients with physicians and dispensaries. Operating in all 50 states with state-specific focus.
• Yes We Cann! National advocacy program operating in all 50 states with state-specific focus. Mobilizes citizen advocates to support medical cannabis legislation and policy.
• The Source (ACCM Source Affinity Program) Comprehensive affinity and group purchasing program providing savings, discounts, and group purchasing agreements for products and services to ACCM members. Includes ACCM Partners for Success, ACCM Accelerators for Success, and ACCM Business Network.
• Midmarket Coalition CEO peer network enabling members to tap collective experiences and knowledge through professionally facilitated virtual and in-person group sessions. Provides access to a network of over 8,000 members of the industry.
• ACCM Distinction Program Industry standards initiative providing tools, structure, and guidance for professional business operation. Includes a 14-point framework for operational integrity, continuous improvement, and industry-wide best practices.
• ACCM Leaders Bureau National resource agency connecting media outlets, legislators, and events with medical cannabis industry thought leaders, physicians, business leaders, and experts for PR and speaking opportunities.
• Next Frontier Program connecting the medical cannabis industry with third-party payers and insurance organizations. Standardizes third-party interaction with ACCM's program and platform for patient processing.
• Policy Action Institute Virtual policy event bringing together elected officials, policy experts, and influential speakers to explore medical cannabis legislation, research, and federal policy topics. Registration fees: Non-Member $200, Member $100, Discounted $75, Student $50.
• AIM Trade Missions Trade mission program connecting American medical cannabis with the world. Programs for domestic and international groups including meetings with industry leaders, legislators, medical experts, and facility tours.
• Medical Cannabis Monthly ACCM's flagship monthly member magazine providing medical-cannabis professionals with clinical and professional news, top trends, innovation features, expert commentary, research summaries, and member profiles.
• Medical Cannabis Awareness Month Annual public health observance (July 11 - Aug 10) celebrating medical cannabis advances and educating the public, physicians, healthcare industry, and legislators about medical cannabis programming.
• ACCM Core Organizational initiative for members committed to driving industry change, providing opportunities to participate in industry conference calls and public testimony.

Quantifiable outcome

• Nearly 1 million advocacy contacts reached through Yes We Cann! program
• +3 more outcomes

Named customers6 records

Segments7 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Partnerships

17 partnerships are on record, tiered core and minor.

• Patient First CoalitioncoreStrategic or Co-development Partner · 18 April 2025ACCM announced support for Patient First Coalition's MAHA efforts to provide expert resources for Committees and Councils. Seven ACCM leaders selected to serve on key 22-person committee writing recommendations for schedule change. ACCM is supporting DEA scheduling order and guidelines for rescheduling from Schedule I to III.
• Direct Primary Care SocietyminorStrategic or Co-development Partner · 20 December 2024Partnership to provide medical cannabis education and resources for DPCS patients, expanding access to medical cannabis information through primary care providers.
• Wellness Live!minorGTM or Marketing Partner · 30 September 2023Selected as 'Official Medical Cannabis' partner for the new streaming platform, providing content and education through multimedia channel.
• Miller UnitedminorStrategic or Co-development Partner · 25 August 2023Selected as exclusive partner organization in 'The Source' providing malpractice insurance to physicians, addressing one of the key barriers to physician participation in medical cannabis.
• Chiropractic AssociationminorStrategic or Co-development Partner · 15 June 2023Selected as partner organization with leading Chiropractic Association. Working group underway with program to start fall 2023, expanding healthcare provider outreach.
• Performance HealthminorStrategic or Co-development Partner · 10 April 2023Insurance leader partnership where Performance Health uses ACCM standardized program and platform for patient processing, advancing insurance integration for medical cannabis.
• National Health Care Sharing AssociationminorStrategic or Co-development Partner · 26 August 2022Selected as strategic alliance partner to begin working with the health care sharing industry, expanding healthcare model integration for medical cannabis.
• EM2P2/CannaLnxcoreStrategic or Co-development Partner · 20 April 2021Signatory of landmark MOU with over 200 stakeholders. EM2P2/CannaLnx is described as an industry-leading company originating in traditional medicine. Gennaro Luce serves as ACCM Medical Industry Committee Co-Chair. Company focused on translation of real science merged into current medical practices.
• Zermatt Medical InstitutecoreStrategic or Co-development Partner · 20 April 2021Signatory of landmark MOU. Dr. Annabelle Manalo-Morgan serves as Zermatt Medical Institute Research Committee Chairperson and ACCM Clinical Research Committee Co-Chair. Focused on clinical research and medical cannabis implementation.
• Dragonfly WellnesscoreStrategic or Co-development Partner · 20 April 2021Utah-based vertically integrated company (cultivation, extraction, processing, retail pharmacy). Narith Panh serves as Chief Strategy Officer and ACCM Cannabis Industry Liaison Committee Member. Committed to helping medical cannabis patients ethically, professionally, and affordably.
• GreenBookAcademycoreStrategic or Co-development Partner · 20 April 2021Signatory of landmark MOU. Noemi Perez serves as CEO, Director for NACDT, and ACCM Education Committee Co-Chair. Pioneer in medical cannabis education with focus on professionalism and industry standards.
• Healthcare Freedom HubcoreStrategic or Co-development Partner · 20 April 2021Signatory of landmark MOU representing healthcare freedom organizations collaborating on issues affecting medical-cannabis industry and moving industry toward traditional healthcare models.
• Member First Health NetworkcoreStrategic or Co-development Partner · 20 April 2021Signatory of landmark MOU. ACCM announced pharmacies and dispensaries aligning to fill out full nationwide network in all legal states opening January 30, 2025.
• Association Health PartnerscoreStrategic or Co-development Partner · 20 April 2021Signatory of landmark MOU sharing insights about moving the industry toward traditional healthcare models enabled under reasonable federal legislation.
• American Society of Cannabis Medicine (ASCM)coreStrategic or Co-development Partner · 20 April 2021ACCM works closely with ASCM. Dr. Jeffrey Block is ASCM Board of Regents member and ACCM Medical Community Committee Co-Chair. Dr. Annabelle Manalo-Morgan is ASCM Board of Regents member.
• Next FrontiercoreTechnology or IntegrationACCM Next Frontier program standardizes third party interaction with the program and platform, connecting the medical cannabis industry with insurance and third-party payer organizations.
• Elevated StatescoreChannel Partner/ Reseller/ DistributorSponsored by ACCM, helps increase public awareness and participation through extensive alignment, education and outreach. Operating in all 50 states with state-specific focus.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Patients Out of Time: Patients Out of Time is a patient-focused medical cannabis advocacy organization focused on reform of federal cannabis laws and clinical research access. It represents an adjacent advocacy peer targeting similar patient and policy outcomes as ACCM's Yes We Cann! and Citizen Advocates programs.
• Cannabis Regulators of Color Coalition (CRCC): CRCC is a coalition focused on equitable cannabis policy and regulatory frameworks. It represents an adjacent stakeholder in the medical-cannabis policy ecosystem where ACCM also engages on equity, access, and federal-state regulatory issues.
• National Hemp Association: National Hemp Association is a U.S. trade association representing the industrial hemp industry, including CBD and cannabinoid producers. It shares adjacency with ACCM in cannabis-related plant-based products and federal regulatory advocacy.
• Society of Cannabis Clinicians (SCC): SCC is a professional medical society for physicians and clinicians specializing in cannabis medicine. It overlaps with ACCM's Medical Practitioners and Physicians member segment and clinical research advocacy efforts.
• American Cannabis Nurses Association (ACNA): ACNA is a professional association for nurses working in medical cannabis. It overlaps with ACCM's practitioner-focused programming (Physician Connect, Medical Community Committee) and represents a relevant adjacent professional organization in the medical-cannabis ecosystem.

Direct peers

• National Cannabis Industry Association (NCIA): NCIA is the largest U.S. trade association for the cannabis industry, representing cultivators, processors, retailers, and ancillary businesses. It is the closest direct peer to ACCM, also operating as a Washington D.C.-based advocacy organization with member dues, conferences, and policy focus — though broader in scope to include recreational cannabis.
• Marijuana Policy Project (MPP): MPP is one of the largest U.S. cannabis policy advocacy organizations, focused on state and federal legalization. It competes with ACCM for donor dollars, lobbying influence, and media positioning on federal cannabis reform.
• Cannabis Trade Federation: Cannabis Trade Federation is a national trade association representing cannabis operators, with focus on banking, tax reform (280E), and federal policy. It is a directly comparable trade association peer operating in the same federal advocacy arena as ACCM.
• NORML (National Organization for the Reform of Marijuana Laws): NORML is a long-established cannabis policy reform advocacy organization with grassroots chapters nationwide. It directly competes with ACCM for advocacy mindshare, donor funding, and political influence on federal cannabis rescheduling legislation.

Broad incumbents

• Drug Policy Alliance (DPA): DPA is a major drug policy reform advocacy organization with a broader mandate covering cannabis, harm reduction, and criminal justice. It competes with ACCM for federal policy influence on cannabis rescheduling and broader drug reform funding.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about American Council of Cannabis Medicine